RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

AvKARE 2024-12-11 Health serious FDA
Health · FDA · Recall #FDA-D-0109-2025

Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski,… Recall

Issued December 11, 2024 · AvKARE

In December 2024, AvKARE recalled the Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski,…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

What you should do

  1. 1 Stop using Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski,… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact AvKARE to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
AvKARE
Category
Health
Recall date
December 11, 2024
Units affected
Not reported
Sold at
USA Nationwide
Recall number
FDA-D-0109-2025
Made in
United States
Issuing agency
FDA

In context

  • AvKARE has 10 recalls in our database, including 1 rated Critical.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 737th Health recall we've logged in 2024.
Read the official FDA notice

Related recalls